Pacylex Pharmaceuticals Inc. (Pacylex) is a clinical-stage pharmaceutical company and world leader in developing N-myristoyltransferase inhibitors (NMTis) for cancer. Oral zelenirstat is under ...
In an analysis of 1,034 fit adults aged 70 years and younger, age and genetic features were identified as the factors most ...
Results showed Orca’s treatment, a purified mix of donor-derived T cells and stem cells, was safer than standard transplant ...
Clinical Trials Arena on MSN4d
Cantargia enrols first patient in trial of nadunolimab for AML and MDSSwedish company Cantargia has enrolled the first patient in the Phase Ib/IIa trial of nadunolimab for treating individuals ...
The combined use of two well-known active substances can fight leukemic cells and limit their spread. This is the result of a ...
Gene mutations in acute myeloid leukemia (AML) cells can guide treatment options, and machine learning can rapidly guess the ...
Actimab-A is a humanized anti-CD33 antibody conjugated to Actinium-225 (Ac-225). With its potent alpha-particle payload ...
Faced with an impossible choice after their son's cancer diagnosis, a local family is trying to slow down time. If the odds ...
Researchers from Karl Landsteiner University of Health Sciences (KL Krems) have discovered that combining two existing drugs ...
Anthony Stein, MD, assessed total marrow and lymphoid irradiation with post-transplant cyclophosphamide in patients with ...
Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing the tuspetinib (TUS)-based triple drug frontline therapy to treat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback